Triptorelin Peptide
€150.00
In stock
SKU
350410
Protein Family: Hormones
Pathway and Disease: Endocrine System
Alternate Names: Triptorelin; [d-Trp6]GnRH; gonadotropin-releasing hormone agonist; 6-D-Tryptophan-Luteinizing Hormone-Releasing Factor; D-Trp-6-LH-RH
Accession No.: CAS 57773-63-4
Description:
Triptorelin is a decapeptide synthetic analogue of gonadotropin-releasing hormone (GnRH). It is used as a GnRH agonist in the form of an acetate or pamoate salt. Triptorelin decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH), subsequently decreasing testosterone levels. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions such as andometriosis or uterine fibroids, and in assisted reproduction. It is also used as therapy for gender identity disorder.
Format:
Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as an acetate salt.
MW: 1311.5 g/mol
Sequence:
H-pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 or H-pEHWSYwLRPG-NH2
Composition:
C64H83N18O13
Purity:
> 95% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
Pathway and Disease: Endocrine System
Alternate Names: Triptorelin; [d-Trp6]GnRH; gonadotropin-releasing hormone agonist; 6-D-Tryptophan-Luteinizing Hormone-Releasing Factor; D-Trp-6-LH-RH
Accession No.: CAS 57773-63-4
Description:
Triptorelin is a decapeptide synthetic analogue of gonadotropin-releasing hormone (GnRH). It is used as a GnRH agonist in the form of an acetate or pamoate salt. Triptorelin decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH), subsequently decreasing testosterone levels. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions such as andometriosis or uterine fibroids, and in assisted reproduction. It is also used as therapy for gender identity disorder.
Format:
Each vial contains 1 mg of lyophilized solid packaged under an inert gas and supplied as an acetate salt.
MW: 1311.5 g/mol
Sequence:
H-pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 or H-pEHWSYwLRPG-NH2
Composition:
C64H83N18O13
Purity:
> 95% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, aliquot and store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review